Biomeditsina va amaliyot jurnali, 2022 №4

Тема статьи

BETA-THALASSEMIA: THE STATE OF THE PROBLEM AND PROSPECTS (REVIEW) (72-79)

Авторы

АССЕСОРОВА Юлиана Юрьевна Республиканский специализированный научно-практический медицинский центр гематологии

Учреждение

Республиканский специализированный научно-практический медицинский центр гематологии

Аннотация

Makolada b-thalassemia kasalligini tarkalishi, patogenezi va xususiyiyatlari tugrisida shu kungacha tuplangan ma'lumotlar tahlili kilingan, ushbu gemoglobinopathiesani tashhislash va davolashning asosiy clinics usullari tibbiy yordam ko'rsatish. Adabiy ma'lumotlar shuni ko'rsatadiki, beta-thalassemia muammosi, avvalo, Osiyo va O'rta er dengizi mintaklari hududlari uchun tibbiy va ijtimoiy zhihatdan kuchli yordam beradi. Zamonaviy sharaitda b- thalassemia bilan davolash va davolashni tibbiy kasallikni samarali, hafsiz tejamkor usullarini topishga, beams pathologyning asemptomatic tashuvchiniqlashga imkon beradigan prophylaxis y kasalliklardagi screening dasturlarini ishlab chiqarishga. Tashhislash va tozalashning samarali usullarini ishlab chikish bthalassemia patogenesining molecule asoslarini ko'paytirish mutationlarning populyatsion deterministic spectrini bilish rivojlanishi ogir shakli bilan kasallangan bolalarni tugilishining holati fritters. Kalit suzlar: b-talassemiya, mutatsiyalar, tashhis qo'yish, muammo olish

Ключевые слова

Kalit suzlar: b-talassemiya, mutatsiyalar, tashhis qo'yish, muammo olish

Литературы

1. Needs T, Gonzalez-Mosquera LF, Lynch DT. Beta Thalassemia. 2022 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30285376. 2. Makis A, Hatzimichael E, Papassotiriou I, Voskaridou E. 2017 Clinical trials update in new treatments of β-thalassemia. Am J Hematol. 2016 Nov;91(11):1135-1145. doi: 10.1002/ajh.24530. PMID: 27502996. 3. Hu S, Zhan W, Wang J, Xie J, Zhou W, Yang X, et al. Establishment and application of a novel method based on single nucleotide polymorphism analysis for detecting β-globin gene cluster deletions. Sci Rep. 2020 Oct 26;10(1):18298. doi: 10.1038/s41598-020-75507-6. PMID: 33106596. 4. De Sanctis V, Kattamis C, Canatan D, Soliman AT, Elsedfy H, Karimi M, et al. β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. Mediterr J Hematol Infect Dis. 2017 Feb 20;9(1):e2017018. doi: 10.4084/MJHID.2017.018. PMID: 28293406. 5. Murad H, Moasses F, Dabboul A, Mukhalalaty Y, Bakoor AO, Al-Achkar W, et al. Geographical distribution of β-globin gene mutations in Syria. Hematology. 2018 Oct;23(9):697-704. doi: 10.1080/10245332.2018.1461291. PMID: 29637841. 6. Gunes AK, Gozden HE. The Spectrum of Beta-Thalassemia Mutations in Syrian Refugees and Turkish Citizens. Cureus. 2021 Jun 4;13(6):e15434. doi: 10.7759/cureus.15434. PMID: 34258108. 7. Thein SL. Molecular basis of β thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018 May;70:54-65. doi: 10.1016/j.bcmd.2017.06.001. PMID: 28651846 8. Cabriolu A, Odak A, Zamparo L, Yuan H, Leslie CS, Sadelain M. Globin vector regulatory elements are active in early hematopoietic progenitor cells. Mol Ther. 2022 Mar 2:S1525- 0016(22)00156-3. doi: 10.1016/j.ymthe.2022.02.028. PMID: 35247584. 9. Kountouris P, Lederer CW, Fanis P, Feleki X, Old J, Kleanthous M. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014 Jul 24;9(7):e103020. doi: 10.1371/journal.pone.0103020. PMID: 25058394. 10. Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016 May;38 Suppl 1:32-40. doi: 10.1111/ijlh.12527. PMID: 27183541. 11. Akbarova G. History of the study and solution to the problem of β-thalassemia in azerbaijan // Journal of clinical medicine of Kazakhstan. –2013. –V.4, №30. –р.21-28. 12. Uludağ A, Uysal A, Uludağ A, Ertekin YH, Tekin M, Kütük B, et al. Prevalence and mutations 13. Aydınok Y, Oymak Y, Atabay B, Aydoğan G, Yeşilipek A, Ünal S, et al. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention. Turk J Haematol. 2018 Mar 1;35(1):12-18. doi: 10.4274/tjh.2017.0039. PMID: 28404539. 14. Alsaeed ES, Farhat GN, Assiri AM, Memish Z, Ahmed EM, Saeedi MY, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011-2015. J Epidemiol Glob Health. 2018 Mar;7 Suppl 1(Suppl 1):S41-S47. doi: 10.1016/j.jegh.2017.12.001. PMID: 29801592. 15. Mahajan PS, Kolleri JJ, Ait Souabni S, Prasad S, Belhaddad EH, Mohammed H. Report of a Rare Case of Beta-Thalassemia Major With Subperiosteal Hematomas. Cureus. 2022 Apr 2;14(4):e23770. doi: 10.7759/cureus.23770. PMID: 35509765. 16. Sabath DE. Molecular Diagnosis of Thalassemias and Hemoglobinopathies: An ACLPS Critical Review. Am J Clin Pathol. 2017 Jul 1;148(1):6-15. doi: 10.1093/ajcp/aqx047. PMID: 28605432. 17. Origa R. β-Thalassemia. Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. PMID: 27811859. 18. Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K. Update in Laboratory Diagnosis of Thalassemia. Front Mol Biosci. 2020 May 27;7:74. doi: 10.3389/fmolb.2020.00074. PMID: 32671092. 19. Chen P, Yu X, Huang H, Zeng W, He X, Liu M, et al. Evaluation of Ion Torrent next-generation sequencing for thalassemia diagnosis. J Int Med Res. 2020 Dec;48(12):300060520967778. doi: 10.1177/0300060520967778. PMID: 33342339. 20. Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014 Oct;31(7):583-96. 21. Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, et al. Current status of betathalassemia and its treatment strategies. Mol Genet Genomic Med. 2021 Dec;9(12):e1788. doi: 10.1002/mgg3.1788. PMID: 34738740. 22. Saliba A, Taher A. Iron overload in transfusion-dependent thalassemia. Hematology. 2015 Jun;20(5):311-2. doi: 10.1179/1024533215Z.000000000365. PMID: 25967377. 23. Siri-Angkul N, Chattipakorn SC, Chattipakorn N. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients. Expert Rev Hematol. 2018 Jun;11(6):471-479. doi: 10.1080/17474086.2018.1476134. PMID: 29754517. 24. Şanlidağ B, Çağin B, Özenli Ö, Şahaloğlu Ö, Dalkan C, Galip N, et al. Prevalence of Thalassemia Trait & Iron Deficiency Anemia during Infancy in 2011-2013 in a Thalassemia Prevalent Region: North Cyprus. Iran J Public Health. 2016 Aug;45(8):1038-1043